Document is current

Article History

Received: 8 September 2024

Accepted: 3 March 2025

First Online: 14 March 2025

Declarations

:

: In the primary study, all participants were considered vulnerable because they were living with an incurable illness in the palliative phase. Therefore, ethical considerations and sensitivity were heightened to safeguard the patients during the recruitment and data collection phases. The second author monitored patients’ well-being to prevent undue stress during the interview process. Participants received written and oral information about the study and provided written consent for participation. We informed all participants that they were free to withdraw at any time without explanation. The study was approved by the Norwegian Agency for Shared Services in Education and Research (ref. no. 732136).

: Not Applicable.

: The authors declare no competing interests.